Concurrent chemoradiotherapy versus radiotherapy alone after induction chemoimmunotherapy for stage III NSCLC patients who did not undergo surgery: a single institution retrospective study

With remarkable success and few side effects, induction chemoimmunotherapy has been used to improve the prognosis of patients with resectable or potentially resectable non-small cell lung cancer (NSCLC), even ...

Source: Radiation Oncology - July 25, 2023 Category: Cancer & Oncology Authors: Song Guan, Kai Ren, Xuyu Zhang, Meng Yan, Xue Li and Lujun Zhao Tags: Research Source Type: research